Registry Study of Anaplastic Large Cell Lymphoma Linked to Breast Implants in Adults

What this Trial Is About

Researchers are studying anaplastic large cell lymphoma associated with breast implants BIA-ALCL, a rare disease that affects only women with breast implants. Due to the low number of cases and the unique nature of this lymphoma subtype, French authorities have recommended creating a registry to collect information on these patients. This registry is open in France and Belgium and is coordinated with a national multidisciplinary meeting for expert review. This study is observational and does not involve any treatment or intervention. It collects data on patients diagnosed with BIA-ALCL to better understand the disease and monitor overall response over a 13-year period. The registry serves as a resource for gathering clinical information and supporting expert consensus discussions. Participants in this registry provide information on their condition, which is reviewed regularly during the multidisciplinary meetings. Researchers track overall response as the primary outcome over 13 years. The study helps to gather long-term data on this rare lymphoma without affecting the usual care patients receive from their own doctors.

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry